https://www.ibtimes.co.uk/ebola-crisi...urvive-1467487

Makes sense, Ebola is Rna virus afterall. The Zmapp we used here at Emory Universitty on the two Ebola victims are monoclonal antibodies and are very hard to manufacture and very expensive to produce. They are also volatile and easily denigrated so you need to have ideal refrigeration and high tech transport. You also have to keep administrating the substrate over and over again. I give this guy Kudos for innovation and using what he had at hand and at a much lower cost....